Company news

Zelira Therapeutics Ltd. news in 2020

Zelira Therapeutics Ltd.'s news releases, calls and decks from 2020, newest first.

View company

Zelira Expands HOPE Distribution to Washington DC, USA

December 13, 2020

R&D Tax Incentive Refund

December 10, 2020

ZLD Partners with SprinJene to Launch CBD Toothpaste in US

December 1, 2020

Emyria Deal and Autism Observational Trial for HOPE Products

November 8, 2020

September 2020 Quarterly Report

October 29, 2020

HOPE launches in Australia after TGA approves release

October 26, 2020

Thorney Becomes a Substantial Strategic Investor in Zelira

September 22, 2020

Zenivol launches in Australia after TGA approves release

September 16, 2020

Zelira Forms Subsidiary to Launch Oral Care Products in USA

September 7, 2020

Appendix 4E & Financial Statements

August 28, 2020

HOPE Range Of Products Launches In Louisiana

August 19, 2020

ZLD Successfully Completes $8.75M Oversubscribed Placement

August 3, 2020

June 2020 Quarterly Report

July 30, 2020

Zelira Enters Deal to Develop Products For Vascular Diseases

July 21, 2020

Zelira Phase 1 Chronic Pain Trial Meets Clinical Endpoints

July 13, 2020

TasAlk to Manufacture Zeliras Insomnia and HOPE products

May 25, 2020

March 2020 Quarterly Report

April 29, 2020

Insomnia Trial Meets Primary and Secondary Endpoints

April 7, 2020

Appendix 4D & FY20 Interim Financial Report

February 28, 2020

Phase 1 Opioid Reduction Clinical Trial Fully Enrolled

February 26, 2020

Zelira Meets Primary Endpoints for Insomnia Trial

February 18, 2020

Zelira Successfully Completes Capital Raising of $4.6M

February 4, 2020

December 2019 Quarterly Report

January 31, 2020

Zelira to Collaborate with the Parkinsons Foundation

January 27, 2020

Decks in 2020